NCT06269939 Theory-Driven Manualized Approach to Improving New Learning and Memory in Healthy Aging and MCI
| NCT ID | NCT06269939 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kessler Foundation |
| Condition | Aging |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-12-15 |
| Primary Completion | 2027-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-12-15 with a primary completion date of 2027-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in an aging population.
Eligibility Criteria
Inclusion Criteria: * Inclusion Criteria: * read and speak English fluently Exclusion Criteria: * prior stroke or neurological injury/disease (i.e. traumatic brain injury, Multiple Sclerosis, or Stroke). * history of significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis). * significant alcohol or drug abuse history (inpatient treatment). * Benzodiazepines and steroid use * Diagnosis of dementia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06269939 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06269939 currently recruiting?
Yes, NCT06269939 is actively recruiting participants. Contact the research team at nbmoore@kesslerfoundation.org for enrollment information.
Where is the NCT06269939 trial being conducted?
This trial is being conducted at East Hanover, United States.
Who is sponsoring the NCT06269939 clinical trial?
NCT06269939 is sponsored by Kessler Foundation. The trial plans to enroll 40 participants.